Earth Science Tech (ETST) Common Equity (2012 - 2026)
Earth Science Tech's (ETST) quarterly Common Equity came in at $7.0 million in Q1 2026, up 82.82% YoY from $3.9 million in Q1 2025, and up 21.33% on a QoQ basis from $5.8 million in Q4 2025.
Earth Science Tech (ETST) Common Equity (2012 - 2026) Analysis & Trends
Earth Science Tech (ETST) has 13 years of Common Equity data on file, last reported at $7.0 million in Q1 2026.
- Quarterly Common Equity rose 82.82% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.0 million (up 82.82% YoY) and the FY2026 annual result came in at $7.0 million, up 82.82% from the prior year.
- Common Equity grew to $7.0 million in Q1 2026, from $5.8 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $7.0 million in Q1 2026 to a low of -$2.0 million in Q3 2022.
- A 5-year average of $2.2 million and a median of $2.2 million in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity retreated 20.71% — and 2023, when it surged 352.5%.
- Tracing ETST's Common Equity over 5 years: stood at -$870350.0 in 2022, then surged by 352.5% to $2.2 million in 2023, then soared by 49.27% to $3.3 million in 2024, then soared by 76.9% to $5.8 million in 2025, then rose by 21.33% to $7.0 million in 2026.
- The last three Common Equity figures came in at $7.0 million (Q1 2026), $5.8 million (Q4 2025), and $5.1 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.32 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.53 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.74 Bn | 17.85 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.95 Bn | - | 4.05 Bn |
| 10 | Earth Science Tech | 31.63 Mn | 28.84 Mn | 6.28 Mn | 7.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.36 Mn |
| Mar 31, 2026 | 7.04 Mn |
| Dec 31, 2025 | 5.80 Mn |
| Sep 30, 2025 | 5.08 Mn |
| Jun 30, 2025 | 4.29 Mn |
| Mar 31, 2025 | 3.85 Mn |
| Dec 31, 2024 | 3.28 Mn |
| Sep 30, 2024 | 3.20 Mn |
| Jun 30, 2024 | 3.17 Mn |
| Mar 31, 2024 | 2.25 Mn |
| Dec 31, 2023 | 2.20 Mn |
| Sep 30, 2023 | 1.97 Mn |
| Jun 30, 2023 | 1.53 Mn |
| Mar 31, 2023 | 1.12 Mn |
| Dec 31, 2022 | -870,350.00 |
| Sep 30, 2022 | -2.03 Mn |
| Jun 30, 2022 | -1.96 Mn |
| Mar 31, 2022 | -1.81 Mn |
| Dec 31, 2021 | -1.78 Mn |
| Sep 30, 2021 | -1.68 Mn |